NCT06119958View on ClinicalTrials.gov

Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 27, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Drug Drug Interaction
Interventions
DRUG

DWC202313

Experimental Drug 1

DRUG

DWC202314

Experimental Drug 2

Trial Locations (1)

Unknown

RECRUITING

H Plus YANGJI Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

NCT06119958 - Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects | Biotech Hunter | Biotech Hunter